메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

BEIJING, Aug. 28, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a revised preliminary non-binding proposal letter (the "Revised Proposal Letter"), dated August 26, 2025, from a consortium (the "Consortium") comprised of Oceanpine Investme
- 김갑성 기자
- 2025-08-28 20:00
뉴소프트 메디컬 시스템즈의 광자 계수 CT, 중국 최초 NMPA 승인

[ 메디채널 김갑성 기자 ] 선양, 중국 2025년 8월 28일 -- 의료 영상 솔루션 및 서비스 분야의 글로벌 선도기업 뉴소프트 메디컬 시스템즈(Neusoft Medical Systems)가 27일 자사의 NeuViz P10 광자 계수 CT(photon-counting CT)가 중국 국가약품감독관리국(National Medical Products Administration•NMPA)으로부터 시판 허가를 받았다고 밝혔다. 중국에서 광자 계수 CT가 승인된 건 NeuViz P10가 처음이다. NeuViz P10는 전 세계 최초로 8cm 검출기를 탑재한 와이드 바디 시스템이다. 광자 계수 CT는 차세대 영상 기술의 혁신으로 간주된다. X선을 먼저 빛으로 변환한 후 디지털 영상을 생성하는 기존 CT 스캐너와 달리 NeuViz P10은 카드뮴•아연•텔루라이드(CZT) 검출기를 사용해 각 X선 광자를 직접 포착해 디지털 신호로 변환한다. 이러한 직접적인 접근 방식은 훨씬 더 선명한 영상을 제공하고 환자의 방사선 노출을 줄이면서 서로 다른 종류의 조직을 구별하는 능력을 향상시킨다. 이러한 발전 덕분에 환자 심장의 미세 혈관을
- 김갑성 기자
- 2025-08-28 19:41
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi

[ 메디채널 김갑성 기자 ] Committed to net-zero across the value chain by 2050 Aligned with 1.5°C mitigation pathways, the most ambitious SBTi designation Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, Aug. 28, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its near-term and net-zero greenhouse gas (GHG) emissions reduction targets have been approved by the Science Based Targets initiative (SBTi). WuXi Biologics is one of the first companies in the industry t
- 김갑성 기자
- 2025-08-28 17:00
Futurise Lead RegTalk 2025: AI Medical Devices in Malaysia - Balancing Innovation and Safety

CYBERJAYA, Malaysia, Aug. 28, 2025 -- Futurise Sdn Bhd (Futurise), in collaboration with the Medical Device Authority (MDA), hosted the latest edition of RegTalk at the Siemens Healthineers Experience Center, focusing on "AI Medical Devices in Malaysia – Balancing Innovation & Safety." The session brought together regulators, industry leaders, and policy experts to explore the opportunities and challenges of artificial intelligence in healthcare. The discussion highlighted the critical balance between fostering innovation and ensuring patient safety, clinical vali
- 김갑성 기자
- 2025-08-28 15:01
Top Thermal Camera Manufacturer Raytron Makes Breakthroughs in Scientific Research

YANTAI, China, Aug. 28, 2025 -- As research in AI, advanced materials, renewable energy, and climate research accelerates, scientists require highly sensitive, precise, stable, and cost-effective tools to explore the invisible. Infrared thermal imaging has emerged as a vital "invisible microscope", enabling researchers to visualize heat flow, distribution, and transformation in real time. Raytron, with multi-spectral sensing R&D expertise, focuses on core infrared technologies and delivers full-spectrum SWIR, MWIR, and LWIR solutions for diverse applications. How Raytron'
- 김갑성 기자
- 2025-08-28 14:00
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.

AUCKLAND, New Zealand, Aug. 27, 2025 -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a Novel Tissue Apposition Device (ENIVO™) Following Simple Unilateral Mastectomy, which was published in the well-respected journal, Plastic and Reconstructive Surgery, Global Open. The ENIVO platform is designed for the management of 'dead space,' which is an open cavity created by surgical separation or excision of sof
- 김갑성 기자
- 2025-08-28 12:29
CNA-Featured Mindset Coach Sharanya V Tackles Parenthood, Marriage & Identity Amid Singapore's Mental Health Push

With mental health now on Singapore's national agenda, efforts are underway to shift support into the community and reduce over-medicalisation. Recently featured by CNA Lifestyle, mindset coach and counsellor Sharanya V contributes to this conversation by addressing the everyday emotional pressures of parenthood, marriage and identity. SINGAPORE, Aug. 28, 2025 -- Sharanya V, a Singapore-based mindset coach and mental health counsellor, was recently featured by CNA Lifestyle as one of eight best podcasts for women in Singapore for her show The Parenting Revival Podcast. The recognition
- 김갑성 기자
- 2025-08-28 11:09
Chulalongkorn University Launches "ER-VIPE," a VR Innovation for Interprofessional Emergency Team Training to Enhance Patient Safety

BANGKOK, Aug. 28, 2025 -- Because Every Minute in the ER Matters, the Chulalongkorn University Design for Society Center (CUD4S), in collaboration with the Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital of the Thai Red Cross Society, has launched the "ER-VIPE" (Emergency Room – Virtual Interprofessional Education), an innovative medical education tool. Using virtual simulation technology, ER-VIPE is designed to train interprofessional teams—doctors, nurses, pharmacists, radiologic technologist
- 김갑성 기자
- 2025-08-28 10:00
ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics

SEOUL, South Korea, Aug. 28, 2025 -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic Memorandum of Understanding (MOU) with DAAN Biotherapeutics, a clinical-stage biotech focused on precision immuno-oncology therapeutics. Through this agreement, the two companies will establish a multi-faceted collaboration framework including stable supply of high-performance bioreagents, technical cooperation for immuno-oncology drug development, and joint resea
- 김갑성 기자
- 2025-08-28 09:54
Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision

TOKYO, Aug. 28, 2025 -- Fujitsu today announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provision in Japan's healthcare sector. The new platform includes an orchestrator AI agent, a centralized system that supports the collaboration and coordination of multiple specialized healthcare-specific agents developed by Fujitsu and other partner companies. The initiative aims to contribute to the rapid implementation of world-leading medical operational practices, thereby driving business transformation and imp
- 김갑성 기자
- 2025-08-28 08:40

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-08-30_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 08월 30일 17시 20분